Fibrin degradation products and plasminogen in newborn infants with respiratory disturbances and postnatal asphyxia.
D001034:Apgar Score; D001238:Asphyxia Neonatorum / Q000097:blood* / Q000401:mortality; D001769:Blood; D002543:Cerebral Hemorrhage / Q000097:blood; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D005342:Fibrinolysis; D005865:Gestational Age; D006801:Humans; D006819:Hyaline Membrane Disease / Q000097:blood; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D007744:Obstetric Labor Complications; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011247:Pregnancy; D011248:Pregnancy Complications; D011379:Prognosis; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood* / Q000401:mortality; D013997:Time Factors
D005337:Fibrin; D005340:Fibrinogen; D010100:Oxygen